Center For Scientific Review; Notice of Closed Meetings, 19669-19670 [2012-7821]
Download as PDF
<![CDATA[
19669
Federal Register / Vol. 77, No. 63 / Monday, April 2, 2012 / Notices
EXHIBIT 1—ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Number of
respondents
Data collection
Total ..........................................................................................................
Number of
responses per
respondent
192
Hours per
response
Total burden
hours
na
na
58
EXHIBIT 2—ESTIMATED ANNUALIZED COST BURDEN
Number of
respondents
Data collection
Average
hourly
wage rate*
Total burden
hours
Total cost
burden
Demographic Questionnaire ............................................................................
S-TOFHLA Questionnaire ................................................................................
Health Education Materials & Interview—English, Inhaler ..............................
Health Education Materials & Interview —English & Spanish, Colonoscopy
Health Education Materials & Interview—Spanish, High Blood Pressure ......
48
48
24
48
24
4
6
12
24
12
$21.35
21.35
21.35
21.35
21.35
$85
128
256
512
256
Total ..........................................................................................................
192
58
na
1,237
* Based upon the mean wage for all occupations, National Compensation Survey: Occupational wages in the United States May 2010, ‘‘U.S.
Department of Labor, Bureau of Labor Statistics.’’
Estimated Annual Costs to the Federal
Government
The total cost of this contract to the
government is $524,945, and the project
extends over 3 years (July 19, 2010 to
July 18, 2013). The data collection for
which we are seeking OMB clearance
will take place from September 1, 2012
to December 31, 2012. Exhibit 3 shows
a breakdown of the total cost as well as
the annualized cost for the data
collection, processing and analysis
activity for this entire contract.
EXHIBIT 3—ESTIMATED COST
Cost Component
Total Cost
Annual Cost
Project Development .......................................................................................................................................
Data Collection Activities .................................................................................................................................
Data Processing and Analysis .........................................................................................................................
Publication of Results ......................................................................................................................................
Project Management ........................................................................................................................................
$66,447
129,547
129,548
131,571
67,832
$22,149
43,182
43,183
43,857
22,611
Total ..........................................................................................................................................................
524,945
174,982
mstockstill on DSK4VPTVN1PROD with NOTICES
Request for Comments
In accordance with the Paperwork
Reduction Act, comments on AHRQ’s
information collection are requested
with regard to any of the following: (a)
Whether the proposed collection of
information is necessary for the proper
performance of AHRQ health care
research and health care information
dissemination functions, including
whether the information will have
practical utility; (b) the accuracy of
AHRQ’s estimate of burden (including
hours and costs) of the proposed
collection(s) of information; (c) ways to
enhance the quality, utility, and clarity
of the information to be collected; and
(d) ways to minimize the burden of the
collection of information upon the
respondents, including the use of
automated collection techniques or
other forms of information technology.
Comments submitted in response to
this notice will be summarized and
included in the Agency’s subsequent
request for OMB approval of the
VerDate Mar<15>2010
17:42 Mar 30, 2012
Jkt 226001
proposed information collection. All
comments will become a matter of
public record.
Dated: March 22, 2012.
Carolyn M. Clancy,
Director.
[FR Doc. 2012–7768 Filed 3–30–12; 8:45 am]
BILLING CODE 4160–90–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center For Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for
Scientific Review Special Emphasis
Panel; Neurodegeneration: Mechanisms
and Therapeutic Targets.
Date: April 17, 2012.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
6701 Rockledge Drive, Bethesda, MD
20892 (Telephone Conference Call).
Contact Person: Laurent Taupenot,
Ph.D, Scientific Review Officer, Center
for Scientific Review, National Institutes
of Health, 6701 Rockledge Drive, Room
4811, MSC 7850, Bethesda, MD 20892,
301–435–1203, taupenol@csr.nih.gov.
Name of Committee: Center for
Scientific Review Special Emphasis
E:\FR\FM\02APN1.SGM
02APN1
19670
Federal Register / Vol. 77, No. 63 / Monday, April 2, 2012 / Notices
Panel; Member conflict: Chemosensory,
Pain and Hearing.
Date: April 18–19, 2012.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
6701 Rockledge Drive, Bethesda, MD
20892 (Virtual Meeting).
Contact Person: John Bishop, Ph.D,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room
5182, MSC 7844, Bethesda, MD 20892,
(301) 408–9664, bishopj@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: March 27, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–7821 Filed 3–30–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2012–N–0294]
Agency Information Collection
Activities; Proposed Collection;
Comment Request; Food Contact
Substance Notification Program
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing an
opportunity for public comment on the
proposed collection of certain
information by the Agency. Under the
Paperwork Reduction Act of 1995 (the
PRA), Federal Agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension of an existing collection of
information, and to allow 60 days for
public comment in response to the
notice. This notice solicits comments on
the collection of information associated
with the Food Contact Substance
Notification Program, including
revisions to Form FDA 3480, new Form
FDA 3480A, and electronic submission
via the Electronic Submission Gateway
(ESG).
DATES: Submit either electronic or
written comments on the collection of
information by May 29, 2012.
mstockstill on DSK4VPTVN1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
17:42 Mar 30, 2012
Jkt 226001
Submit electronic
comments on the collection of
information to https://
www.regulations.gov. Submit written
comments on the collection of
information to the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, rm.
1061, Rockville, MD 20852. All
comments should be identified with the
docket number found in brackets in the
heading of this document.
FOR FURTHER INFORMATION CONTACT:
With regard to the information
collection: Denver Presley, Jr., Office of
Information Management, Food and
Drug Administration, 1350 Piccard Dr.,
PI50–400B, Rockville, MD 20850, 301–
796–3793.
With regard to the Food Contact
Substance Notification Program:
Kenneth A. McAdams, Center for Food
Safety and Applied Nutrition, Food and
Drug Administration, 5100 Paint Branch
Pkwy (HFS–275), College Park, MD
20740, 240–402–1224, Fax: 301–436–
2965, email:
Kenneth.mcadams@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: Under the
PRA (44 U.S.C. 3501–3520), Federal
Agencies must obtain approval from the
Office of Management and Budget
(OMB) for each collection of
information they conduct or sponsor.
‘‘Collection of information’’ is defined
in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes Agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA (44
U.S.C. 3506(c)(2)(A)) requires Federal
Agencies to provide a 60-day notice in
the Federal Register concerning each
proposed collection of information,
including each proposed extension of an
existing collection of information,
before submitting the collection to OMB
for approval. To comply with this
requirement, FDA is publishing notice
of the proposed collection of
information set forth in this document.
With respect to the following
collection of information, FDA invites
comments on these topics: (1) Whether
the proposed collection of information
is necessary for the proper performance
of FDA’s functions, including whether
the information will have practical
utility; (2) the accuracy of FDA’s
estimate of the burden of the proposed
collection of information, including the
validity of the methodology and
assumptions used; (3) ways to enhance
the quality, utility, and clarity of the
information to be collected; and (4)
ways to minimize the burden of the
collection of information on
ADDRESSES:
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
respondents, including through the use
of automated collection techniques,
when appropriate, and other forms of
information technology.
Food Contact Substance Notification
Program—21 CFR 170.101, 170.106,
and 171.1 (OMB Control Number 0910–
0495)—Revision
Section 409(h) of the Federal Food,
Drug, and Cosmetic Act (the FD&C Act)
(21 U.S.C. 348(h)) establishes a
premarket notification process for food
contact substances. Section 409(h)(6) of
the FD&C Act defines a ‘‘food contact
substance’’ as ‘‘any substance intended
for use as a component of materials used
in manufacturing, packing, packaging,
transporting, or holding food if such use
is not intended to have any technical
effect in such food.’’ Section 409(h)(3) of
the FD&C Act requires that the
notification process be used for
authorizing the marketing of food
contact substances except when: (1)
FDA determines that the submission
and premarket review of a food additive
petition (FAP) under section 409(b) of
the FD&C Act is necessary to provide
adequate assurance of safety or (2) FDA
and the manufacturer or supplier agree
that an FAP should be submitted.
Section 409(h)(1) of the FD&C Act
requires that a notification include: (1)
Information on the identity and the
intended use of the food contact
substance and (2) the basis for the
manufacturer’s or supplier’s
determination that the food contact
substance is safe under the intended
conditions of use.
Sections 170.101 and 170.106 (21 CFR
170.101 and 170.106) specify the
information that a notification must
contain and require that: (1) A food
contact substance notification (FCN)
include a completed and signed Form
FDA 3480 and (2) a notification for a
food contact substance formulation
include a completed and signed Form
FDA 3479. These forms serve to
summarize pertinent information in the
notification. The forms facilitate both
preparation and review of notifications
because the forms serve to organize
information necessary to support the
safety of the use of the food contact
substance. The burden of filling out the
appropriate form has been included in
the burden estimate for the notification.
Currently, interested persons transmit
an FCN submission to the Office of Food
Additive Safety in the Center for Food
Safety and Applied Nutrition using
Form FDA 3480 whether it is submitted
in electronic or paper format. FDA
recently made minor revisions to Form
FDA 3480 to better enable its use for
electronic submission and to prompt
E:\FR\FM\02APN1.SGM
02APN1
]]>Agencies
[Federal Register Volume 77, Number 63 (Monday, April 2, 2012)]
[Notices]
[Pages 19669-19670]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-7821]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center For Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Neurodegeneration: Mechanisms and Therapeutic Targets.
Date: April 17, 2012.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Laurent Taupenot, Ph.D, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 4811, MSC 7850, Bethesda, MD 20892, 301-435-1203,
taupenol@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
[[Page 19670]]
Panel; Member conflict: Chemosensory, Pain and Hearing.
Date: April 18-19, 2012.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: John Bishop, Ph.D, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5182, MSC 7844, Bethesda, MD 20892, (301) 408-
9664, bishopj@csr.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: March 27, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2012-7821 Filed 3-30-12; 8:45 am]
BILLING CODE 4140-01-P
